
Rheumatology & autoimmunity, Journal Year: 2023, Volume and Issue: 3(4), P. 193 - 204
Published: Dec. 1, 2023
Abstract Lupus nephritis (LN), an immune complex‐mediated glomerulonephritis, is one of the most severe complications systemic lupus erythematosus. Current therapeutic regimens for LN mainly involve nonspecific immunosuppressants and biologics targeting cells, but these treatments are not always effective some patients nonresponsive susceptible to recurrence. Podocytes essential maintaining glomerular filtration barrier. Injury loss podocytes lead proteinuria, a hallmark renal involvement LN. are, therefore, emerging as prospective targets There numerous mechanisms underlying podocyte malfunction in LN, with autophagy, mitochondrial dysregulation, programmed cell death being main processes behind loss. This review summarizes recent advances understanding dysfunction pathogenesis discusses potential interventions
Language: Английский